O
OMPI N.A. S DE RL DE CV
Stevanato Group specializes in world-class systems, processes, and services for the Pharmaceutical and Healthcare industry. The company was established in 1949 and is headquartered out of Veneto, Italy.
Country/Area ：Mexico
Company Email ：service@stevanatogroup.com
Industry ：Health & MedicalMedical Devices & EquipmentManufacturingPackaging & PrintingSchool & Office Supplies
Company address ：17 Via Molinella, Piombino Dese, Veneto, 35017, Italy
Company website ：*****
Company phone ：+39 499318111
Established ：1949
Company Revenue ：$910,490,000
Number of employees ：4652
SIC Code ：30308
NAICS Code ：33339
Main Products ：labeling, packaging & serializationPrefillable SyringesFlexible packaging machinesDrug Containment SolutionsR&D fill and finishPoint-of-Care DevicesChemical AnalysisLarge Volume CartridgesAssembly EquipmentInspection TechnologiesGLASS CONVERTINGHandling systemsEZ-fill platformSpecialty product linesContainer TraceabilityHandling SystemsContainer interactionTailored ServicesANALYTICAL & TESTING SERVICESSemi-AutomaticMedical SolutionsIn-Vitro Diagnostics & Medical SolutionsDual Chamber CartridgesRegulatory SupportIn-Vitro Diagnostics ConsumablesAssembly platformsLDP VialsSurface CharacterizationVISUAL INSPECTION SYSTEMSContainer performance
Company News
Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing
Nov 16, 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life science industries, announced today that its Mavis™ Combi visual inspection machine has been selected as a winner of the 2023 Pharma Innovation Awards by Pharma Manufacturing, a brand of Endeavor Business Media. The Pharma Innovation Awards represent an annual recognition of new technologies and services that aim
Nov 16, 2023
Stevanato Group to Present at the Jefferies London Healthcare ConferenceNov 9, 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Jefferies London Healthcare Conference taking place from November 14, 2023 to November 16, 2023. The Company will present on Wednesday, November 15, 2023 at 10:00 a.m. GMT. A live webcast will be available on the Company
Nov 9, 2023Stevanato Group Reports Third Quarter 2023 Financial ResultsOct 31, 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter of 2023. Third Quarter 2023 Highlights (compared with the same period last year) Third quarter revenue increased 11% to €271.4 million. Revenue from high-value solutions increased to 32% of total revenue. Net
Oct 31, 2023Stevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023Oct 17, 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the third quarter of 2023 on Tuesday, October 31, 2023, at 6:30 a.m. (ET). Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Tuesday, October 31, 2023 to discu
Oct 17, 2023Stevanato Group Announces Voting Results from its Extraordinary General MeetingOct 5, 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announced today that the resolution proposed to shareholders at the Extraordinary General Meeting of Shareholders (“EGM”) held virtually on October 4, 2023 was passed. Details of the resolution submitted to, and approved by, the EGM are included in the explanatory report
Oct 5, 2023Web Summary
Q1: What is the company name and its location?
A1: The company name is OMPI N.A. S DE RL DE CV, and it is located in Fishers, Indiana, USA.
Q2: What industry does the company operate in?
A2: The company operates in the pharmaceutical and medical device industry, specifically in the areas of drug containment solutions, drug delivery systems, in-vitro diagnostics, and medical solutions.
Q3: What are some of the products offered by the company?
A3: Some of the products offered by the company include EZ-fill pre-sterilized solutions, EZ-fill Smart™, EZ-fill KIT, syringe systems, integrated tip cap cartridge systems, dual chamber cartridges, large-volume cartridges, vials systems, LDP Vials, microvials, primary container traceability ampoules, specialty product lines, and optimized glass primary packaging.
Q4: What services does the company provide?
A4: The company provides contract manufacturing of devices, proprietary & licensed devices, auto-injectors (Aidaptus®), pen injectors (Alina®), on-body delivery system (Vertiva®), in-vitro diagnostics point of care devices, consumables, medical solutions technologies & equipment, and after-sales services.
Q5: What is the company's focus on sustainability and ESG?
A5: The company aims to align its culture and operations with sustainability and ESG principles, as stated in their vision, mission, and values. They also have a dedicated webpage for ESG and sustainability, which includes information on their SG Steps initiative.
Q6: What is the purpose of the "Whistleblowing" section?
A6: The "Whistleblowing" section provides information on Stevanato Group's whistleblower policy, which aims to encourage employees to report any unethical or illegal behavior within the company.
Q7: How can investors contact Stevanato Group?
A7: Investors can contact Stevanato Group through their website, where they can find information on careers, investor relations, and other relevant details.
Q8: What is the company's vision and mission statement?
A8: The company's vision and mission statement are not explicitly stated in the provided text. However, based on the information provided, it appears that Stevanato Group aims to align its culture and operations with sustainability and ESG principles, while also providing innovative solutions for the pharmaceutical and medical device industries.
A1: The company name is OMPI N.A. S DE RL DE CV, and it is located in Fishers, Indiana, USA.
Q2: What industry does the company operate in?
A2: The company operates in the pharmaceutical and medical device industry, specifically in the areas of drug containment solutions, drug delivery systems, in-vitro diagnostics, and medical solutions.
Q3: What are some of the products offered by the company?
A3: Some of the products offered by the company include EZ-fill pre-sterilized solutions, EZ-fill Smart™, EZ-fill KIT, syringe systems, integrated tip cap cartridge systems, dual chamber cartridges, large-volume cartridges, vials systems, LDP Vials, microvials, primary container traceability ampoules, specialty product lines, and optimized glass primary packaging.
Q4: What services does the company provide?
A4: The company provides contract manufacturing of devices, proprietary & licensed devices, auto-injectors (Aidaptus®), pen injectors (Alina®), on-body delivery system (Vertiva®), in-vitro diagnostics point of care devices, consumables, medical solutions technologies & equipment, and after-sales services.
Q5: What is the company's focus on sustainability and ESG?
A5: The company aims to align its culture and operations with sustainability and ESG principles, as stated in their vision, mission, and values. They also have a dedicated webpage for ESG and sustainability, which includes information on their SG Steps initiative.
Q6: What is the purpose of the "Whistleblowing" section?
A6: The "Whistleblowing" section provides information on Stevanato Group's whistleblower policy, which aims to encourage employees to report any unethical or illegal behavior within the company.
Q7: How can investors contact Stevanato Group?
A7: Investors can contact Stevanato Group through their website, where they can find information on careers, investor relations, and other relevant details.
Q8: What is the company's vision and mission statement?
A8: The company's vision and mission statement are not explicitly stated in the provided text. However, based on the information provided, it appears that Stevanato Group aims to align its culture and operations with sustainability and ESG principles, while also providing innovative solutions for the pharmaceutical and medical device industries.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
